Thanatophoric Dysplasia
Publisher
Springer New York
Reference36 articles.
1. Baker, K. M., Olson, D. S., Harding, C. O., et al. (1997). Long-term survival in typical thanatophoric dysplasia type 1. American Journal of Medical Genetics, 70, 427–436. 2. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., et al. (1996a). Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia. Acta Paediatrica. Supplement, 417, 33–38. 3. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., et al. (1996b). Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. American Journal of Medical Genetics, 63, 148–154. 4. Chen, C. P., Chern, S. R., Shih, J. C., et al. (2001). Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenatal Diagnosis, 21, 89–95. 5. Chen, C. P., Chern, S. R., Chang, T. Y., et al. (2002). Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings. Prenatal Diagnosis, 22, 736–737.
|
|